These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 28296286)

  • 1. Nanomedicine approaches to improve cancer immunotherapy.
    Qiu H; Min Y; Rodgers Z; Zhang L; Wang AZ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28296286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
    Fontana F; Liu D; Hirvonen J; Santos HA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27470448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic plant virology for nanobiotechnology and nanomedicine.
    Steele JFC; Peyret H; Saunders K; Castells-Graells R; Marsian J; Meshcheriakova Y; Lomonossoff GP
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jul; 9(4):. PubMed ID: 28078770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanoparticle mediated cancer immunotherapy.
    Almeida JP; Figueroa ER; Drezek RA
    Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of nanoparticles to deliver immunomodulatory oligonucleotides.
    Klinman DM; Sato T; Shimosato T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):631-7. PubMed ID: 26663867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances of functional nanomaterials for cancer immunotherapeutic applications.
    Hao Y; Zhou X; Li R; Song Z; Min Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1574. PubMed ID: 31566896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology platforms for cancer immunotherapy.
    Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens.
    Fan Y; Moon JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27038091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral chemistry: the chemical functionalization of viral architectures to create new technology.
    Chen Z; Li N; Li S; Dharmarwardana M; Schlimme A; Gassensmith JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):512-34. PubMed ID: 26663821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle formulations of cisplatin for cancer therapy.
    Duan X; He C; Kron SJ; Lin W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):776-91. PubMed ID: 26848041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances of using polyhydroxyalkanoate-based nanovehicles as therapeutic delivery carriers.
    Li Z; Loh XJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 27595635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-based nanoparticles as platform technologies for modern vaccines.
    Lee KL; Twyman RM; Fiering S; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):554-78. PubMed ID: 26782096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation.
    DeLong RK; Curtis CB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27312869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.
    Caster JM; Patel AN; Zhang T; Wang A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27312983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
    Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
    Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendrimer-based nanocarriers: a versatile platform for drug delivery.
    Hsu HJ; Bugno J; Lee SR; Hong S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27126551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.
    Ozcelikkale A; Moon HR; Linnes M; Han B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28198106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
    Liu J; Zhang R; Xu ZP
    Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in preclinical to clinical translation for anticancer carrier-mediated agents.
    Lucas AT; Madden AJ; Zamboni WC
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):642-53. PubMed ID: 26846457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.